August 21, 2017 6:33 AM ET

Biotechnology

Company Overview of Gilead Sciences, Inc.

Executive Profile

John W. Mellors M.D.

Member of the Scientific Advisory Board, Gilead Sciences, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
79--

Background

Dr. John W. Mellors, M.D. is a Professor of Medicine and Chief of Infectious Diseases at the University of Pittsburgh School of Medicine. Dr. Mellors serves as a Member of Scientific Advisory Board at Gilead Sciences Inc. He serves as Member of the HIV Scientific Advisory Board of Idenix Pharmaceuticals Inc. He serves as a Member of the US Public Health Service Panel on Clinical Practices for the Treatment of HIV Infection, and the International AIDS Society-USA Panel ...

Corporate Headquarters

333 Lakeside Drive
Foster City, California 94404

United States

Phone: 650-574-3000
Fax: 650-578-9264

Board Members Memberships

There is no Board Members Memberships data available.

Education

There is no Education data available.

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.CEO & Chairman
Bristol-Myers Squibb Company
$1.5M
Omar S. Ishrak Chairman & CEO
Medtronic plc
$1.5M
Emma Walmsley CEO & Director
GlaxoSmithKline plc
--
David A. Ricks Chairman, Chief Executive Officer & President
Eli Lilly and Company
--
Richard A. Gonzalez Chairman of the Board & Chief Executive Officer
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2016.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Gilead Sciences, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.